From July 1, 2023 to September 21, 2023, the company has repurchased 8,348 shares, representing 0.03% for CAD 0.12 million. With this, the company has completed the repurchase of 284,843 shares, representing 1.13% for CAD 1.03 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.58 CAD | -0.12% | +0.82% | +54.87% |
Mar. 15 | Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024 | |
Mar. 14 | Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.87% | 150M | |
+33.25% | 699B | |
+24.52% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.87% | 236B | |
+4.91% | 198B | |
-10.35% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- CPH Stock
- News Cipher Pharmaceuticals Inc.
- Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on September 19, 2022.